Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Staphylococcus Aureus Endocarditis”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Post-approval studies (Phase 4)WithdrawnNCT03761953
What this trial is testing

Oritavancin for Staphylococcus Aureus Infections in Opioid Users

Who this might be right for
Staphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis
University of Pennsylvania
Not applicableUnknownNCT05522764
What this trial is testing

Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly Staphylococcus Aureus Bacteriuria, and Time to Blood Culture Positivity

Who this might be right for
BacteremiaEndocarditis, Bacterial
Fondation Hôpital Saint-Joseph 247
Not applicableStudy completedNCT01731483
What this trial is testing

Coagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus Infections

Who this might be right for
Infective EndocarditisNecrotizing Fasciitis
Universitaire Ziekenhuizen KU Leuven 89
Not applicableUnknownNCT05862025
What this trial is testing

Evaluation of the Usefulness of Echocardiography in Patients With Staphylococcus Aureus Bacteremia (ET-AUREUS Study).

Who this might be right for
Staphylococcus Aureus BacteremiaInfective Endocarditis
Puerta de Hierro University Hospital 470
Not applicableUnknownNCT06495697
What this trial is testing

Plasma Pharmacological Monitoring of M Penicillins in Methicillin-sensitive Staphylococcus Aureus Bacteremia

Who this might be right for
Staphylococcus Aureus Infection
University Hospital, Strasbourg, France 200
Large-scale testing (Phase 3)Looking for participantsNCT07345325
What this trial is testing

Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditis

Who this might be right for
Infective Endocarditis
Nantes University Hospital 422
Large-scale testing (Phase 3)Ended earlyNCT07253688
What this trial is testing

Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus

Who this might be right for
Staphylococcus Aureus EndocarditisProsthetic Valve Endocarditis
Todd C. Lee MD MPH FIDSA 1
Not applicableUnknownNCT04257292
What this trial is testing

NExt-Generation Sequencing and Cell Culture-based Characterization of S. Aureus in Infective Endocarditis

Who this might be right for
Infective EndocarditisInfection Staphylococcal
Jena University Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT00695903
What this trial is testing

Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia

Who this might be right for
Endocarditis, BacterialInfective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 38
Not applicableLooking for participantsNCT06457386
What this trial is testing

Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3

Who this might be right for
Staphylococcus AureusBacteremiaInfective Endocarditis
Assistance Publique - Hôpitaux de Paris 700
Testing effectiveness (Phase 2)Study completedNCT03163446
What this trial is testing

Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia

Who this might be right for
Staphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis
ContraFect 121
Post-approval studies (Phase 4)Looking for participantsNCT06650501
What this trial is testing

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

Who this might be right for
Staphylococcus Aureus EndocarditisStaphylococcus Aureus SepticemiaStaphylococcus Aureus Bacteremia+3 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 300
Post-approval studies (Phase 4)Looking for participantsNCT06650488
What this trial is testing

Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

Who this might be right for
Staphylococcus Aureus EndocarditisStaphylococcus Aureus SepticemiaStaphylococcus Aureus Bloodstream Infection
Todd C. Lee MD MPH FIDSA 300
Large-scale testing (Phase 3)Study completedNCT03138733
What this trial is testing

Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia

Who this might be right for
Staphylococcus Aureus Bacteremia
Basilea Pharmaceutica 390
Large-scale testing (Phase 3)Study completedNCT00770341
What this trial is testing

MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)

Who this might be right for
Staphylococcal Infection
Merck Sharp & Dohme LLC 122
Not applicableStudy completedNCT00548002
What this trial is testing

Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia

Who this might be right for
Staphylococcus AureusBacteremiaEndocarditis+1 more
University of Helsinki 430
Large-scale testing (Phase 3)Study completedNCT00093067
What this trial is testing

Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus

Who this might be right for
Bacterial EndocarditisBacteremia
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Large-scale testing (Phase 3)Ended earlyNCT04160468
What this trial is testing

Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase

Who this might be right for
Staphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis
ContraFect 259
Post-approval studies (Phase 4)Study completedNCT00871104
What this trial is testing

Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis

Who this might be right for
Infective Endocarditis
Juan A. Arnaiz 50
Post-approval studies (Phase 4)Ended earlyNCT00638157
What this trial is testing

Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)

Who this might be right for
Infective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Next Page